Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).
about
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesPharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseAssociation of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisVitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.Statin improves flow-mediated vasodilation in chronic kidney diseases.Proteinuria after kidney transplantation.Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.
P2860
Q26747425-D583CEC6-2542-4E64-AF3A-F06EF7CB2C62Q26782422-F1BF33D4-4FCD-4CE5-AC3B-C44B125AA46BQ33932951-AFCB332F-B8D5-4050-A74F-C4E9E437FBBAQ36298479-91EC8C15-A2E5-44A5-8361-A00EB75C116BQ37417376-085D4E8A-5C2C-40AA-B248-361C3C82C000Q38012182-EDD84FAD-2EC8-4D20-986B-1C55E531D9EFQ38513740-6C510890-5A98-406E-8FEA-418E75AAB868Q42115221-7C6FB79E-E581-4C51-B6BB-8DEA3B59ED61Q51328717-9004CD0F-6F08-4670-A2F2-C426EDD3CDE4
P2860
Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@ast
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@en
type
label
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@ast
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@en
prefLabel
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@ast
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@en
P2093
P2860
P356
P1476
Atorvastatin reduces proteinur ...... glycation end products (AGEs).
@en
P2093
Eiichi Sato
Masayoshi Takeuchi
Nobuharu Fujiwara
Sayaka Maeda
Sho-ichi Yamagishi
Tsukasa Nakamura
Yasuhiro Kawagoe
P2860
P304
P356
10.4161/OXIM.3.5.13069
P577
2010-09-01T00:00:00Z